These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29593912)

  • 21. Evaluation of Fosfomycin-Sulbactam Combination Therapy against Carbapenem-Resistant
    Mohd Sazlly Lim S; Heffernan A; Naicker S; Wallis S; Roberts JA; Sime FB
    Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36358238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of colistin mono- and combination therapy against colistin-resistant
    Lertsrisatit Y; Santimaleeworagun W; Thunyaharn S; Traipattanakul J
    Infect Drug Resist; 2017; 10():437-443. PubMed ID: 29200878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
    Ku YH; Chen CC; Lee MF; Chuang YC; Tang HJ; Yu WL
    J Microbiol Immunol Infect; 2017 Dec; 50(6):931-939. PubMed ID: 28716360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an
    Bian X; Liu X; Chen Y; Chen D; Li J; Zhang J
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of eravacycline in combination with colistin against carbapenem-resistant A. baumannii isolates.
    Ozger HS; Cuhadar T; Yildiz SS; Demirbas Gulmez Z; Dizbay M; Guzel Tunccan O; Kalkanci A; Simsek H; Unaldi O
    J Antibiot (Tokyo); 2019 Aug; 72(8):600-604. PubMed ID: 31028352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Singkham-In U; Chatsuwan T
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):169-174. PubMed ID: 29433997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii.
    Dong X; Chen F; Zhang Y; Liu H; Liu Y; Ma L
    J Antibiot (Tokyo); 2014 Sep; 67(9):677-80. PubMed ID: 25095805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
    Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ
    J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii.
    Temocin F; Erdinc FS; Tulek N; Demirelli M; Ertem G; Kinikli S; Koksal E
    Braz J Microbiol; 2015; 46(4):1119-24. PubMed ID: 26691470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates.
    Peck KR; Kim MJ; Choi JY; Kim HS; Kang CI; Cho YK; Park DW; Lee HJ; Lee MS; Ko KS
    J Med Microbiol; 2012 Mar; 61(Pt 3):353-360. PubMed ID: 22016557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro interactions of ambroxol hydrochloride or amlodipine in combination with antibacterial agents against carbapenem-resistant Acinetobacter baumannii.
    Wang Y; Li X; Wang D; Sun S; Lu C
    Lett Appl Microbiol; 2020 Mar; 70(3):189-195. PubMed ID: 31808159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro synergy of colistin combinations against extensively drug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase.
    Wei W; Yang H; Liu Y; Ye Y; Li J
    J Chemother; 2016 Jun; 28(3):159-63. PubMed ID: 25978105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro analysis of colistin-carbapenem combination activity against Acinetobacter spp infection.
    Soudeiha M; Sokhn ES; Daoud Z; Sarkis D
    J Infect Dev Ctries; 2018 Feb; 12(2.1):11S. PubMed ID: 31804986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant
    Rodjun V; Houngsaitong J; Montakantikul P; Paiboonvong T; Khuntayaporn P; Yanyongchaikit P; Sriyant P
    Antibiotics (Basel); 2020 Aug; 9(8):. PubMed ID: 32823820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activities of sitafloxacin tested alone and in combination with rifampin, colistin, sulbactam, and tigecycline against extensively drug-resistant Acinetobacter baumannii.
    Dong X; Chen F; Zhang Y; Liu H; Liu Y; Ma L
    Int J Clin Exp Med; 2015; 8(5):8135-40. PubMed ID: 26221381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin-sulbactam combination therapy.
    Srisakul S; Wannigama DL; Higgins PG; Hurst C; Abe S; Hongsing P; Saethang T; Luk-In S; Liao T; Kueakulpattana N; Shein AMS; Gan L; Kupwiwat R; Tanasatitchai C; Wapeesittipan P; Phattharapornjaroen P; Badavath VN; Leelahavanichkul A; Chatsuwan T
    Sci Rep; 2022 Jul; 12(1):11390. PubMed ID: 35794134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro synergism of combinations of colistin with selected antibiotics against colistin-resistant Acinetobacter baumannii.
    Percin D; Akyol S; Kalin G
    GMS Hyg Infect Control; 2014; 9(2):Doc14. PubMed ID: 25152859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Various antibiotic combinations against carbapenem resistant Acinetobacter baumannii infections and in vitro synergy test results (2002-2016)].
    Zarakolu P; Ayaz ÇM; Metan G
    Mikrobiyol Bul; 2018 Apr; 52(2):190-197. PubMed ID: 29933736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
    J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.